Impact of positive margins on survival in patients undergoing esophagogastrectomy for esophageal cancer presented at the poster session of the fifty-first annual meeting of the society of Thoracic Surgeons, San Diego, CA, Jan 24-28, 2015.

Annals of Thoracic Surgery

Volumn 101, Issue 3, 2016, Pages 1060-1067

  Javidfar, Jeffrey ^a   Speicher, Paul J ^a   Hartwig, Matthew G ^a   D'Amico, Thomas A ^a   Berry, Mark F ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; COHORT ANALYSIS; CONFERENCE PAPER; ESOPHAGOGASTRECTOMY; ESOPHAGUS CANCER; ESOPHAGUS SURGERY; FEMALE; GASTRECTOMY; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; LONG TERM SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; ADVERSE EFFECTS; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; DISEASE FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS RESECTION; FACTUAL DATABASE; GASTROESOPHAGEAL JUNCTION; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASM, RESIDUAL; PATHOLOGY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL MODEL; SURVIVAL ANALYSIS; TUMOR INVASION; TUMOR RECURRENCE;

AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; COHORT STUDIES; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84959573691     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2015.09.005     Document Type: Conference Paper

References (31)

1. F. Kamangar, G.M. Dores, and W.F. Anderson Patterns of cancer incidence, mortality and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2006 2137 2159
2. L.N. Brown, S.S. Devesa, and W.-H. Chow Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage and age J Natl Cancer Inst 100 2008 1184 1187
3. K.F. Trivers, S.A. Sabatino, and S.L. Stewart Trends in esophageal cancer incidence by histology, United States, 1998-2003 Int J Cancer 123 2008 1422 1428
4. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J Clin 64 2014 9 29
5. D.P. Kelsen, K.A. Winter, L.L. Gunderson, and et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer J Clin Oncol 25 2007 3719 3725
6. E.C. Paulson, J. Ra, K. Armstrong, and et al. Underuse of esophagectomy as treatment for resectable esophageal cancer Arch Surg 143 2008 1198 1203
7. J.A. Abrams, D.L. Buono, J. Strauss, and et al. Esophagectomy compared with chemoradiation for early stage esophageal cancer in the elderly Cancer 115 2009 4924 4933
8. P. van Hagen, M.C.C.M. Hulshof, J.J.B. van Lanschot, and et al. Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2012 2074 2084
9. B.H. Burmeister, B.M. Smithers, V. Gebski, and et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial Lancet Oncol 6 2005 659 668
10. P. Kountourakis, A.M. Correa, W.L. Hofstetter, and et al. Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience Cancer 117 2011 925 930
11. M. Worni, A.W. Castleberry, B. Gloor, and et al. Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the Surveillance, Epidemiology, and End Results registry from 1998 to 2008 Dis Esophagus 27 2014 662 669
12. P.J. Speicher, X. Wang, B.R. Englum, and et al. Induction chemoradiation therapy before esophagectomy is associated with superior long-term survival for esophageal cancer Dis Esophagus 2014 Sept 12 [E-Pub ahead of print]
13. P.J. Speicher, B.R. Englum, A.M. Ganapathi, and et al. Adjuvant chemotherapy is associated with improved survival after esophagectomy without induction therapy for node-positive adenocarcinoma J Thorac Oncol 10 2015 181 188
14. T. Ng, and M.P. Vezeridis Advances in the surgical treatment of esophageal cancer J Surg Oncol 101 2010 725 729
15. C.D. Wright, J.C. Kucharczuk, S.M. O'Brien, J.D. Grab, and M.S. Allen Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons general thoracic surgery database risk adjustment model J Thorac Cardiovasc Surg 137 2009 587 595
16. J. Ra, E.C. Paulson, J. Kucharczuk, and et al. Postoperative mortality after esophagectomy for cancer: development of a preoperative risk prediction model Ann Surg Oncol 15 2008 1577 1584
17. R.C. Connors, B.C. Reuben, L.A. Neumayer, and D.A. Bull Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients J Am Coll Surg 205 2007 735 740
18. J.B. Dimick, R.M. Wainess, G.R. Upchurch, M.D. Iannettoni, and M.B. Orringer National trends in outcomes for esophageal resection Ann Thorac Surg 79 2005 212 218
19. S.J. Swanson, H.F. Batirel, R. Bueno, and et al. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma Ann Thorac Surg 72 2001 1918 1924
20. T.A. D'Amico McKeown esophagogastrectomy J Thorac Dis 6 Suppl 3 2014 322 324
21. M.F. Berry, B.Z. Atkins, B.C. Tong, D.H. Harpole, T.A. D'Amico, and M.W. Onaitis A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia J Thorac Cardiovasc Surg 140 2010 1266 1271
22. J.D. Birkmeyer, A.E. Siewers, E.V. Finlayson, and et al. Hospital volume and surgical mortality in the United States N Engl J Med 346 2002 1128 1137
23. M.B. Orringer, B. Marshall, A.C. Chang, J. Lee, A. Pickens, and C.L. Lau Two thousand transhiatal esophagectomies: changing trends, lessons learned Ann Surg 246 2007 363 372
24. B.Z. Atkins, A.S. Shah, K.A. Hutcheson, and et al. Reducing hospital morbidity and mortality following esophagectomy Ann Thorac Surg 78 2004 1170 1176
25. A.R. Davies, M.J. Forshaw, A.A. Khan, and et al. Transhiatal esophagectomy in a high volume institution World J Surg Oncol 6 2008 88
26. J.D. Luketich, A. Pennathur, O. Awais, and et al. Outcomes after minimally invasive esophagectomy: review of over 1000 patients Ann Surg 256 2012 95 103
27. C.B. Begg, L.D. Cramer, W.J. Hoskins, and M.F. Brennan Impact of hospital volume on operative mortality for major cancer surgery JAMA 280 1998 1747 1751
28. J.D. Birkmeyer, Y. Sun, A. Goldfaden, N.J. Birkmeyer, and T.A. Stukel Volume and process of care in high-risk cancer surgery Cancer 106 2006 2476 2481
29. J.F. Bosset, M. Gignoux, J.P. Triboulet, and et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus N Engl J Med 337 1997 161 167
30. T.N. Walsh, N. Noonan, D. Hollywood, A. Kelly, N. Keeling, and T.P. Hennessy A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 1996 462 467
31. D. Cunningham, W.H. Allum, S.P. Stenning, and et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 2006 11 20